IBEX LTD (IBEX) Stock Fundamental Analysis

USA Nasdaq NASDAQ:IBEX • BMG4690M1010

31.13 USD
-1.69 (-5.15%)
At close: Feb 10, 2026
31 USD
-0.13 (-0.42%)
After Hours: 2/10/2026, 8:13:36 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to IBEX. IBEX was compared to 87 industry peers in the IT Services industry. IBEX gets an excellent profitability rating and is at the same time showing great financial health properties. IBEX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings could make IBEX a good candidate for value and growth and quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year IBEX was profitable.
  • In the past year IBEX had a positive cash flow from operations.
  • Each year in the past 5 years IBEX has been profitable.
  • Each year in the past 5 years IBEX had a positive operating cash flow.
IBEX Yearly Net Income VS EBIT VS OCF VS FCFIBEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

1.2 Ratios

  • With an excellent Return On Assets value of 14.58%, IBEX belongs to the best of the industry, outperforming 93.10% of the companies in the same industry.
  • IBEX's Return On Equity of 28.81% is amongst the best of the industry. IBEX outperforms 89.66% of its industry peers.
  • IBEX has a Return On Invested Capital of 21.63%. This is amongst the best in the industry. IBEX outperforms 95.40% of its industry peers.
Industry RankSector Rank
ROA 14.58%
ROE 28.81%
ROIC 21.63%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBEX Yearly ROA, ROE, ROICIBEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

1.3 Margins

  • IBEX has a better Profit Margin (7.14%) than 73.56% of its industry peers.
  • IBEX's Profit Margin has improved in the last couple of years.
  • IBEX's Operating Margin of 9.18% is fine compared to the rest of the industry. IBEX outperforms 67.82% of its industry peers.
  • In the last couple of years the Operating Margin of IBEX has grown nicely.
  • IBEX's Gross Margin of 30.62% is in line compared to the rest of the industry. IBEX outperforms 42.53% of its industry peers.
  • In the last couple of years the Gross Margin of IBEX has remained more or less at the same level.
Industry RankSector Rank
OM 9.18%
PM (TTM) 7.14%
GM 30.62%
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
IBEX Yearly Profit, Operating, Gross MarginsIBEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBEX is creating value.
  • IBEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IBEX Yearly Shares OutstandingIBEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
IBEX Yearly Total Debt VS Total AssetsIBEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • IBEX has an Altman-Z score of 5.03. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.03, IBEX belongs to the best of the industry, outperforming 80.46% of the companies in the same industry.
  • The Debt to FCF ratio of IBEX is 0.05, which is an excellent value as it means it would take IBEX, only 0.05 years of fcf income to pay off all of its debts.
  • IBEX has a Debt to FCF ratio of 0.05. This is amongst the best in the industry. IBEX outperforms 93.10% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that IBEX is not too dependend on debt financing.
  • IBEX has a better Debt to Equity ratio (0.01) than 83.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 5.03
ROIC/WACC2.27
WACC9.54%
IBEX Yearly LT Debt VS Equity VS FCFIBEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • IBEX has a Current Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.82, IBEX is in line with its industry, outperforming 55.17% of the companies in the same industry.
  • A Quick Ratio of 1.82 indicates that IBEX should not have too much problems paying its short term obligations.
  • IBEX has a Quick ratio of 1.82. This is comparable to the rest of the industry: IBEX outperforms 55.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.82
IBEX Yearly Current Assets VS Current LiabilitesIBEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 44.77% over the past year.
  • Measured over the past years, IBEX shows a very strong growth in Earnings Per Share. The EPS has been growing by 41.04% on average per year.
  • Looking at the last year, IBEX shows a quite strong growth in Revenue. The Revenue has grown by 9.77% in the last year.
  • IBEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.62% yearly.
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%

3.2 Future

  • Based on estimates for the next years, IBEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.72% on average per year.
  • The Revenue is expected to grow by 9.19% on average over the next years. This is quite good.
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IBEX Yearly Revenue VS EstimatesIBEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
IBEX Yearly EPS VS EstimatesIBEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.00, the valuation of IBEX can be described as very reasonable.
  • Based on the Price/Earnings ratio, IBEX is valued cheaper than 89.66% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of IBEX to the average of the S&P500 Index (28.03), we can say IBEX is valued rather cheaply.
  • A Price/Forward Earnings ratio of 8.60 indicates a reasonable valuation of IBEX.
  • IBEX's Price/Forward Earnings ratio is rather cheap when compared to the industry. IBEX is cheaper than 87.36% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of IBEX to the average of the S&P500 Index (27.97), we can say IBEX is valued rather cheaply.
Industry RankSector Rank
PE 9
Fwd PE 8.6
IBEX Price Earnings VS Forward Price EarningsIBEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 88.51% of the companies in the same industry are more expensive than IBEX, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBEX indicates a somewhat cheap valuation: IBEX is cheaper than 68.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.44
EV/EBITDA 5.97
IBEX Per share dataIBEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of IBEX may justify a higher PE ratio.
  • A more expensive valuation may be justified as IBEX's earnings are expected to grow with 13.72% in the coming years.
PEG (NY)0.39
PEG (5Y)0.22
EPS Next 2Y13.72%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • IBEX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

IBEX LTD

NASDAQ:IBEX (2/10/2026, 8:13:36 PM)

After market: 31 -0.13 (-0.42%)

31.13

-1.69 (-5.15%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners94.08%
Inst Owner Change-0.01%
Ins Owners2.8%
Ins Owner Change0.29%
Market Cap419.32M
Revenue(TTM)558.27M
Net Income(TTM)41.38M
Analysts45.71
Price Target41.82 (34.34%)
Short Float %0.81%
Short Ratio1.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.95%
Min EPS beat(2)20.05%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)16.83%
Min EPS beat(4)10.89%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)12.58%
EPS beat(12)10
Avg EPS beat(12)14.59%
EPS beat(16)12
Avg EPS beat(16)13.3%
Revenue beat(2)2
Avg Revenue beat(2)5.51%
Min Revenue beat(2)2.5%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.65%
Min Revenue beat(4)2.45%
Max Revenue beat(4)8.52%
Revenue beat(8)5
Avg Revenue beat(8)1.79%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)6.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.48%
EPS NY rev (1m)0%
EPS NY rev (3m)5.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.82%
Valuation
Industry RankSector Rank
PE 9
Fwd PE 8.6
P/S 0.72
P/FCF 13.44
P/OCF 7.83
P/B 2.92
P/tB 3.18
EV/EBITDA 5.97
EPS(TTM)3.46
EY11.11%
EPS(NY)3.62
Fwd EY11.63%
FCF(TTM)2.32
FCFY7.44%
OCF(TTM)3.98
OCFY12.78%
SpS43.04
BVpS10.66
TBVpS9.78
PEG (NY)0.39
PEG (5Y)0.22
Graham Number28.81
Profitability
Industry RankSector Rank
ROA 14.58%
ROE 28.81%
ROCE 26.64%
ROIC 21.63%
ROICexc 24.4%
ROICexgc 26.15%
OM 9.18%
PM (TTM) 7.14%
GM 30.62%
FCFM 5.38%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 129.83%
Cap/Sales 3.86%
Interest Coverage 31.53
Cash Conversion 76.01%
Profit Quality 75.39%
Current Ratio 1.82
Quick Ratio 1.82
Altman-Z 5.03
F-Score8
WACC9.54%
ROIC/WACC2.27
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.48%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year68.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.26%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y19.11%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%

IBEX LTD / IBEX FAQ

Can you provide the ChartMill fundamental rating for IBEX LTD?

ChartMill assigns a fundamental rating of 7 / 10 to IBEX.


What is the valuation status for IBEX stock?

ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.


What is the profitability of IBEX stock?

IBEX LTD (IBEX) has a profitability rating of 7 / 10.


What is the valuation of IBEX LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for IBEX LTD (IBEX) is 9 and the Price/Book (PB) ratio is 2.92.


Is the dividend of IBEX LTD sustainable?

The dividend rating of IBEX LTD (IBEX) is 0 / 10 and the dividend payout ratio is 0%.